The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial

E. I. Schwarz, C. Schlatzer, J. Stehli, P. A. Kaufmann, K. E. Bloch, J. R. Stradling, M. Kohler (Zurich, Switzerland; Oxford, United Kingdom)

Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Session: Real or not? The impact of OSA and CPAP on comorbid conditions
Session type: Oral Presentation
Number: 4664
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. I. Schwarz, C. Schlatzer, J. Stehli, P. A. Kaufmann, K. E. Bloch, J. R. Stradling, M. Kohler (Zurich, Switzerland; Oxford, United Kingdom). The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial. Eur Respir J 2014; 44: Suppl. 58, 4664

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



OSAS treatment with CPAP: Randomized crossover study comparing tolerance and efficacy with and without humidification
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Positional therapy as a treatment for central sleep apnoea: A prospective multicentre trial
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016

OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Nasal steroids in snorers can decrease snoring frequency – A randomized placebo-controlled crossover trial
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014


A randomized controlled trial of a novel sleep surface for treatment of positional sleep apnea
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016


A prospective, randomised, controlled trial of CPAP in adults with Down syndrome
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


LATE-BREAKING ABSTRACT: Zonisamide reduces obstructive sleep apnea: A randomized placebo-controlled study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

The micro-RNA hsa-miR-502-3p is down-regulated in the plasma of obstructive sleep apnea patients after 2 weeks of continuous positive airway pressure therapy withdrawal: Data from a randomized controlled trial
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

Telemedicine-based strategy for sleep apnea management: A multicenter randomized controlled trial
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014

A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013

Randomized short–term trial of high span versus low span APAP for the treatment of obstructive sleep apnea
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014

REM rebound during CPAP titration as a predictor of chronic CPAP compliance
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


The effect of CPAP on quality of life in patients with ‘very’ mild Obstructive Sleep Apnoea (OSA): Results from a subset of the MERGE Randomised Trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016



Tri-level ventilation versus CPAP treatment in treatment of complex sleep apnoea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

Evaluating the impact of patient-selected CPAP interface on the treatment of OSA
Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings
Year: 2016